KOCAA
MURA

Knights of Columbus Asset Advisors’s Mural Oncology MURA Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10
Closed -$32 – 382
2024
Q4 		$32 Hold
10
– – ﹤0.01% 380
2024
Q3 		$31 Buy
+10
New +$33 ﹤0.01% 392

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knights of Columbus Asset Advisors's MURA Position: Q1 2025 in Review

Knights of Columbus Asset Advisors sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 10 shares — an estimated $32 sold.

Knights of Columbus Asset Advisors first reported a position in MURA in Q3 2024 and held it in 2 quarters. The position peaked at $32 in Q4 2024. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Knights of Columbus Asset Advisors reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 10 Mural Oncology shares in Q1 2025, an estimated $32.
  • Knights of Columbus Asset Advisors first reported a position in Mural Oncology in Q3 2024 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Mural Oncology position peaked at $32 in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2025, filed 7 May 2025.